title: Obligate ordered binding of human lactogenic cytokines.
abstract: Class 1 cytokines bind two receptors to create an active heterotrimeric complex. It has been argued that ligand binding to their receptors is an ordered process, but a structural mechanism describing this process has not been determined. We have previously described an obligate ordered binding mechanism for the human prolactin/prolactin receptor heterotrimeric complex. In this work we expand this conceptual understanding of ordered binding to include three human lactogenic hormones: prolactin, growth hormone, and placental lactogen. We independently blocked either of the two receptor binding sites of each hormone and used surface plasmon resonance to measure human prolactin receptor binding kinetics and stoichiometries to the remaining binding surface. When site 1 of any of the three hormones was blocked, site 2 could not bind the receptor. But blocking site 2 did not affect receptor binding at site 1, indicating a requirement for receptor binding to site 1 before site 2 binding. In addition we noted variable responses to the presence of zinc in hormone-receptor interaction. Finally, we performed Förster resonance energy transfer (FRET) analyses where receptor binding at subsaturating stoichiometries induced changes in FRET signaling, indicative of binding-induced changes in hormone conformation, whereas at receptor:hormone ratios in excess of 2:1 no additional changes in FRET signaling were observed. These results strongly support a conformationally mediated obligate-ordered receptor binding for each of the three lactogenic hormones.
authors.affiliation: The Ohio State Biochemistry Program, The Ohio State University, 1925 Coffey Rd., Columbus, OH 43210, USA.
authors.forename: Jeffery L
authors.initials: JL
authors.lastname: Voorhees
authors.forename: Charles L
authors.initials: CL
authors.lastname: Brooks
mesh_terms: D001665:Binding Sites / Q000235:genetics; D001667:Binding, Competitive / Q000187:drug effects; D016207:Cytokines / Q000737:chemistry / Q000235:genetics / Q000378:metabolism; D005260:Female; D031541:Fluorescence Resonance Energy Transfer; D013006:Growth Hormone / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007700:Kinetics; D009154:Mutation; D010928:Placental Lactogen / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011247:Pregnancy; D011388:Prolactin / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D011485:Protein Binding / Q000187:drug effects; D011487:Protein Conformation; D011981:Receptors, Prolactin / Q000737:chemistry / Q000235:genetics / Q000378:metabolism*; D020349:Surface Plasmon Resonance; D015032:Zinc / Q000378:metabolism / Q000494:pharmacology
chemical_list: D016207:Cytokines; D011981:Receptors, Prolactin; D011388:Prolactin; D013006:Growth Hormone; D010928:Placental Lactogen; D015032:Zinc